Selank Reconstitution Guide: Step-by-Step Laboratory Protocol for Research Use
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
Selank Reconstitution Guide: Step-by-Step Laboratory Protocol for Research Use
Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro, MW 751.88 g/mol, CAS 129954-34-3) is a synthetic heptapeptide analogue of Tuftsin studied in neuronal cell models for GABA-A receptor modulation, BDNF pathway activity, and neuropeptide signalling endpoint characterisation. It is supplied as a lyophilised white powder in a 10mL sterile glass vial containing 5mg of peptide. Selank is highly water-soluble and reconstitutes readily with bacteriostatic water for neurological cell model research.
Materials Required
- Selank 5mg lyophilised vial
- Bacteriostatic water (BAC water) — 10mL vial
- 1mL sterile syringe with needle
- Alcohol swabs (70% isopropyl)
- Nitrile gloves
- Permanent marker for labelling
- Refrigerator at 2–8°C for storage
Pre-Reconstitution Preparation
Inspect the Selank vial to confirm intact lyophilised powder and unbroken seal. Remove from cold storage and allow to equilibrate to room temperature for 10 minutes. Selank's heptapeptide structure and highly polar amino acid composition (Thr, Lys, Arg, Pro, Gly) confer excellent aqueous solubility — dissolution is rapid and straightforward.
Step-by-Step Reconstitution Protocol
Step 1 — Prepare workspace. Wipe work surface with 70% isopropyl alcohol and allow to dry. Wear nitrile gloves throughout.
Step 2 — Swab both stoppers. Clean rubber stoppers of both vials with separate fresh alcohol swabs. Air dry 10 seconds each.
Step 3 — Draw 2mL of BAC water. Draw 2mL of bacteriostatic water into a sterile syringe.
Step 4 — Inject along the vial wall. Direct BAC water slowly down the inner glass wall of the Selank vial over 10–15 seconds. Avoid direct stream onto the lyophilised powder.
Step 5 — Dissolve gently. Swirl gently for 15–20 seconds. Selank dissolves very rapidly — the solution should be clear and colourless almost immediately. Do not shake or vortex.
Step 6 — Inspect and label. Confirm full clarity. Label with reconstitution date, concentration (2.5mg/mL), and initials.
Resulting Concentration
Adding 2mL BAC water to a 5mg Selank vial yields a stock concentration of 2.5mg/mL (2500mcg/mL). For GABA-A receptor modulation assays and neuronal cell model studies in SH-SY5Y, GT1-7, or primary cortical neuron preparations, working concentrations of 0.1nM–10mcg/mL are prepared by serial dilution into assay buffer or neurobasal media.
Concentration Reference Table
| BAC Water Volume Added | Resulting Concentration |
|---|---|
| 1mL | 5.0mg/mL (5000mcg/mL) |
| 2mL | 2.5mg/mL (2500mcg/mL) |
| 5mL | 1.0mg/mL (1000mcg/mL) |
Storage Conditions and Stability
Store lyophilised Selank at −20°C prior to reconstitution, protected from light and moisture. Once reconstituted, store at 2–8°C. Reconstituted Selank in BAC water is stable for up to 28 days under refrigeration. Selank's proline-rich sequence (three Pro residues) confers resistance to many endopeptidases, contributing to relative stability in serum-containing media compared to non-proline-rich peptides. Do not freeze reconstituted solution. Prepare single-use aliquots at −80°C for long-term working stock storage.
Troubleshooting Common Reconstitution Issues
Powder not dissolving: If any powder adheres to the glass wall, gently tilt and swirl the vial to bring it into contact with the solvent. Do not heat the vial. If dissolution remains incomplete after 60 seconds of gentle swirling, inspect the vial for signs of moisture ingress or a previously compromised seal.
Cloudy solution: A correctly reconstituted solution should be clear and colourless. Cloudiness may indicate peptide aggregation, microbial contamination, or particulate introduction. Discard the vial if cloudiness persists after gentle swirling and re-inspection.
Foaming: If foam forms, allow it to settle naturally without shaking. Foaming typically results from injecting the solvent too quickly or directly onto the powder — direct the stream along the glass wall and reduce injection speed on subsequent attempts.
Loss of material on vial walls: Swirl the vial so the reconstituted solution contacts all inner wall surfaces before drawing. For maximum peptide recovery, invert the vial and draw from the stopper end after complete dissolution.
Research Application Notes
Selank's GABA-A modulating activity in neuronal cell models distinguishes it from most research peptides which target GPCRs or receptor tyrosine kinases. For GABA-A receptor assay applications, standard patch clamp electrophysiology in primary cortical neurons or Xenopus oocyte expression systems provides the most sensitive functional readout. In biochemical assay formats, GABA-A receptor-mediated chloride influx (using Cl- fluorescent indicators) or membrane potential assays (FLIPR-based) provide higher-throughput alternatives. Include a GABA reference agonist (10µM GABA) and benzodiazepine positive allosteric modulator control (diazepam, 1µM) in all GABA-A functional assay panels to contextualise Selank's pharmacology relative to established reference compounds. Selank 5mg vials are available from Pinnacle Peptides, verified at ≥99% purity by HPLC and mass spectrometry.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
